Presenting a new paradigm for incurable dental diseases for the first time through reactivation of poorly functioning or aged tooth cells
· Completion of dental specialized technology platform Dentopine by utilizing HysensBio peptide, the world’s first developed dentin regenerative peptide
· Development of treatment for dentin hypersensitivity, dental caries and periodontal disease by developing prescription drugs that regenerate physiologic dentin
· Completion of technology for incurable dental diseases by developing veterinary dental medicine and alveolar bone regenerative technology
Development of therapeutics through the activation of permanent adult cells that do not divide or differentiate
Rejuvenation of the original cell function through reactivation of dormant permanent adult cell
Research Area on Cell Activation
with the Development of PACA Platform Technology